Articles: sars-cov-2.

• Latest
• Best
• Search…

• Ann. Intern. Med. · Aug 2024

  Comment Letter Practice Guideline

  Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2, Update Alert).

  no abstract available

  expand abstract… or not…

• Critical care medicine · Aug 2024

  Editorial

  The Omicron Paradox: Is It Omicron or Is It What Happened During the Omicron Period?

  no abstract available

  read more… or not…

• Ann. Intern. Med. · Aug 2024

  Comment Letter Review

  Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Evidence Review for the American College of Physicians (Version 2, Update Alert).

  no abstract available

  expand abstract… or not…

• Niger J Clin Pract · Aug 2024

  Repurposing of Anti-Cancer Drugs Against Moderate and Severe COVID Infection: A Network-Based Systems Biological Approach.

  The COVID-19 pandemic caused by SARS-CoV-2 is an unparalleled health risk, needing fast antiviral medication development. One of the most effective strategies for developing therapies against novel and emerging viruses is drug repurposing. Recently, systems biology approaches toward the discovery of repurposing medications are gaining prominence. ⋯ Interestingly, some of the proposed drugs have demonstrated inhibitory effects against SARS-CoV-2, as supported by literature evidence. Overall, the drug repurposing method described here will help develop potential antiviral medications to treat emerging COVID strains.

  explore further… or not…

• Journal of critical care · Aug 2024

  Letter

  Authors' response: "Brain magnetic resonance imaging findings six months after critical COVID-19: A prospective cohort study".

  no abstract available

  keep reading… or not…